Cargando…

Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market

INTRODUCTION: Antimicrobial use is associated with emergence of antimicrobial resistance. We report hospital antimicrobial procurement, as a surrogate for consumption in humans, expenditure and prices in public hospitals in Vietnam, a lower middle-income country with a high burden of drug resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dat, Vu Quoc, Toan, Phan Khanh, van Doorn, H. Rogier, Thwaites, C. Louise, Nadjm, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575121/
https://www.ncbi.nlm.nih.gov/pubmed/33079967
http://dx.doi.org/10.1371/journal.pone.0240830
_version_ 1783597755034238976
author Dat, Vu Quoc
Toan, Phan Khanh
van Doorn, H. Rogier
Thwaites, C. Louise
Nadjm, Behzad
author_facet Dat, Vu Quoc
Toan, Phan Khanh
van Doorn, H. Rogier
Thwaites, C. Louise
Nadjm, Behzad
author_sort Dat, Vu Quoc
collection PubMed
description INTRODUCTION: Antimicrobial use is associated with emergence of antimicrobial resistance. We report hospital antimicrobial procurement, as a surrogate for consumption in humans, expenditure and prices in public hospitals in Vietnam, a lower middle-income country with a high burden of drug resistant infections. METHOD: Data on antimicrobial procurement were obtained from tender-winning bids from provincial health authorities and public hospitals with detailed bids representing 28.7% (1.68 / 5.85 billion US $) of total hospital medication spend in Vietnam. Antimicrobials were classified using the Anatomical Therapeutic Chemical (ATC) Index and the 2019 WHO Access, Watch, Reserve (AWaRe) groups. Volume was measured in number of Defined Daily Doses (DDD). Antimicrobial prices were presented per DDD. RESULTS: Expenditure on systemic antibacterials and antifungals accounted for 28.6% (US $482.6 million/US $1.68 billion) of the total drug bids. 83% of antibacterials (572,698,014 DDDs) by volume (accounting for 45.5% of the antibacterials spend) were domestically supplied. Overall, the most procured antibacterials by DDD were second generation cephalosporins, combinations of penicillins and beta-lactamase inhibitors, and penicillins with extended spectrum. For parenteral antibacterials this was third generation cephalosporins. The average price for antibacterials was US $15.6, US $0.86, US $0.4 and US $11.7 per DDD for Reserve, Watch, Access and non-recommended/unclassified group antibacterials, respectively. CONCLUSIONS: Antimicrobials accounted for a substantial proportion of the funds spent for medication in public hospitals in Vietnam. The pattern of antibacterial consumption was similar to other countries. The high prices of Reserve group and non-recommended/unclassified antibacterials suggests a need for a combination of national pricing and antimicrobial stewardship policies to ensure appropriate accessibility.
format Online
Article
Text
id pubmed-7575121
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-75751212020-10-26 Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market Dat, Vu Quoc Toan, Phan Khanh van Doorn, H. Rogier Thwaites, C. Louise Nadjm, Behzad PLoS One Research Article INTRODUCTION: Antimicrobial use is associated with emergence of antimicrobial resistance. We report hospital antimicrobial procurement, as a surrogate for consumption in humans, expenditure and prices in public hospitals in Vietnam, a lower middle-income country with a high burden of drug resistant infections. METHOD: Data on antimicrobial procurement were obtained from tender-winning bids from provincial health authorities and public hospitals with detailed bids representing 28.7% (1.68 / 5.85 billion US $) of total hospital medication spend in Vietnam. Antimicrobials were classified using the Anatomical Therapeutic Chemical (ATC) Index and the 2019 WHO Access, Watch, Reserve (AWaRe) groups. Volume was measured in number of Defined Daily Doses (DDD). Antimicrobial prices were presented per DDD. RESULTS: Expenditure on systemic antibacterials and antifungals accounted for 28.6% (US $482.6 million/US $1.68 billion) of the total drug bids. 83% of antibacterials (572,698,014 DDDs) by volume (accounting for 45.5% of the antibacterials spend) were domestically supplied. Overall, the most procured antibacterials by DDD were second generation cephalosporins, combinations of penicillins and beta-lactamase inhibitors, and penicillins with extended spectrum. For parenteral antibacterials this was third generation cephalosporins. The average price for antibacterials was US $15.6, US $0.86, US $0.4 and US $11.7 per DDD for Reserve, Watch, Access and non-recommended/unclassified group antibacterials, respectively. CONCLUSIONS: Antimicrobials accounted for a substantial proportion of the funds spent for medication in public hospitals in Vietnam. The pattern of antibacterial consumption was similar to other countries. The high prices of Reserve group and non-recommended/unclassified antibacterials suggests a need for a combination of national pricing and antimicrobial stewardship policies to ensure appropriate accessibility. Public Library of Science 2020-10-20 /pmc/articles/PMC7575121/ /pubmed/33079967 http://dx.doi.org/10.1371/journal.pone.0240830 Text en © 2020 Dat et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dat, Vu Quoc
Toan, Phan Khanh
van Doorn, H. Rogier
Thwaites, C. Louise
Nadjm, Behzad
Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
title Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
title_full Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
title_fullStr Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
title_full_unstemmed Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
title_short Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
title_sort purchase and use of antimicrobials in the hospital sector of vietnam, a lower middle-income country with an emerging pharmaceuticals market
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575121/
https://www.ncbi.nlm.nih.gov/pubmed/33079967
http://dx.doi.org/10.1371/journal.pone.0240830
work_keys_str_mv AT datvuquoc purchaseanduseofantimicrobialsinthehospitalsectorofvietnamalowermiddleincomecountrywithanemergingpharmaceuticalsmarket
AT toanphankhanh purchaseanduseofantimicrobialsinthehospitalsectorofvietnamalowermiddleincomecountrywithanemergingpharmaceuticalsmarket
AT vandoornhrogier purchaseanduseofantimicrobialsinthehospitalsectorofvietnamalowermiddleincomecountrywithanemergingpharmaceuticalsmarket
AT thwaitesclouise purchaseanduseofantimicrobialsinthehospitalsectorofvietnamalowermiddleincomecountrywithanemergingpharmaceuticalsmarket
AT nadjmbehzad purchaseanduseofantimicrobialsinthehospitalsectorofvietnamalowermiddleincomecountrywithanemergingpharmaceuticalsmarket